Karyopharm Therapeutics Inc. (KPTI) SEC filings
KPTI SEC filings moved a median of -3.15% by the close. KPTI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KPTI overview →
79 measured KPTI SEC filing events.
Where these KPTI SEC filings landedvs 79 measured KPTI SEC filing reactions
| Middle 50% of KPTI SEC filing reactions | -6.28% to +0.95% |
|---|---|
| Median reaction (to close) | -3.15% |
| Measured reactions | 79 |
Point-in-time · zero look-ahead
Half of the 79 KPTI SEC filing events with a measured close landed between -6.28% and +0.95%; 34% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Karyopharm Therapeutics For: Sep 17 | SEC filing · Form 8-K | -1.08% | +0.54% | |
| Form 8-K Karyopharm Therapeutics For: Sep 10 | SEC filing · Form 8-K | +6.00% | +7.33% | |
| Form 8-K Karyopharm Therapeutics For: Aug 31 | SEC filing · Form 8-K | -0.32% | +8.42% | |
| Form 10-Q Karyopharm Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.80% | -3.87% | |
| Form 8-K Karyopharm Therapeutics For: Aug 13 | SEC filing · Form 8-K | +0.80% | -3.87% | |
| Form 8-K Karyopharm Therapeutics For: Jul 30 | SEC filing · Form 8-K | +7.31% | -12.33% | |
| Form 8-K Karyopharm Therapeutics For: Jul 13 | SEC filing · Form 8-K | -7.41% | -20.95% | |
| Form 8-K Karyopharm Therapeutics For: May 21 | SEC filing · Form 8-K | -0.88% | -0.22% | |
| Form S-8 Karyopharm Therapeutics | SEC filing · Form S-8 | -0.95% | +1.45% | |
| Form EFFECT Karyopharm Therapeutics | SEC filing · Form EFFECT | -0.24% | -12.84% | |
| Form 10-Q Karyopharm Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +5.58% | -6.32% | |
| Form 8-K Karyopharm Therapeutics For: May 14 | SEC filing · Form 8-K | +5.58% | -6.32% | |
| Form S-3 Karyopharm Therapeutics | SEC filing · Form S-3 | +2.26% | +1.07% | |
| Form ARS Karyopharm Therapeutics For: Dec 31 | SEC filing · Form ARS | +1.63% | +4.02% | |
| Form DEF 14A Karyopharm Therapeutics For: Apr 13 | SEC filing · Form DEF | +1.63% | +4.02% | |
| Form 8-K Karyopharm Therapeutics For: Mar 27 | SEC filing · Form 8-K | +1.81% | -0.54% | |
| Form 8-K Karyopharm Therapeutics For: Mar 24 | SEC filing · Form 8-K | +2.48% | -10.08% | |
| Form 8-K Karyopharm Therapeutics For: Feb 27 | SEC filing · Form 8-K | -1.10% | -4.60% | |
| Form 8-K Karyopharm Therapeutics For: Feb 18 | SEC filing · Form 8-K | -0.93% | -0.31% | |
| Form 10-K Karyopharm Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.45% | -4.45% | |
| Form 8-K Karyopharm Therapeutics For: Feb 12 | SEC filing · Form 8-K | +14.73% | +33.04% | |
| Form 8-K Karyopharm Therapeutics For: Jan 12 | SEC filing · Form 8-K | -3.85% | -5.15% | |
| Form DEF 14A Karyopharm Therapeutics For: Feb 18 | SEC filing · Form DEF | -3.85% | -5.15% | |
| Form PRE 14A Karyopharm Therapeutics For: Dec 30 | SEC filing · Form PRE | +0.41% | +0.68% | |
| Form 10-Q Karyopharm Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +1.55% | +4.66% | |
| Form 8-K Karyopharm Therapeutics For: Nov 03 | SEC filing · Form 8-K | +1.55% | +4.66% | |
| Form S-3 Karyopharm Therapeutics | SEC filing · Form S-3 | -4.17% | -5.83% | |
| Form 8-K Karyopharm Therapeutics For: Oct 10 | SEC filing · Form 8-K | -1.50% | -1.00% | |
| Form 8-K Karyopharm Therapeutics For: Oct 07 | SEC filing · Form 8-K | -3.16% | +24.21% | |
| Form 8-K Karyopharm Therapeutics For: Sep 05 | SEC filing · Form 8-K | +0.45% | -3.15% | |
| Form 10-Q Karyopharm Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -5.78% | -5.75% | |
| Form 8-K Karyopharm Therapeutics For: Aug 11 | SEC filing · Form 8-K | -5.78% | -5.75% | |
| Form S-8 Karyopharm Therapeutics | SEC filing · Form S-8 | -5.78% | -5.75% | |
| Form 8-K Karyopharm Therapeutics For: Jul 11 | SEC filing · Form 8-K | -7.01% | +8.08% | |
| Form 8-K Karyopharm Therapeutics For: May 28 | SEC filing · Form 8-K | -6.70% | -6.25% | |
| Form 10-Q Karyopharm Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.30% | -14.44% | |
| Form 8-K Karyopharm Therapeutics For: May 12 | SEC filing · Form 8-K | -1.30% | -14.44% | |
| Form ARS Karyopharm Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.00% | -3.22% | |
| Form DEF 14A Karyopharm Therapeutics For: May 28 | SEC filing · Form DEF | +0.00% | -3.22% | |
| Form DEFA14A Karyopharm Therapeutics | SEC filing · Form DEFA14A | +0.00% | -3.22% | |
| Form 8-K Karyopharm Therapeutics For: Feb 24 | SEC filing · Form 8-K | -0.02% | -4.85% | |
| Form 10-K Karyopharm Therapeutics For: Dec 31 | SEC filing · Form 10-K | -14.03% | -2.69% | |
| Form 8-K Karyopharm Therapeutics For: Feb 19 | SEC filing · Form 8-K | -14.03% | -2.69% | |
| Form 8-K Karyopharm Therapeutics For: Jan 27 | SEC filing · Form 8-K | +0.08% | +0.34% | |
| Form 8-K Karyopharm Therapeutics For: Jan 30 | SEC filing · Form 8-K | +0.01% | -6.32% | |
| Form 8-K Karyopharm Therapeutics For: Jan 13 | SEC filing · Form 8-K | -0.69% | -3.89% | |
| Form 8-K Karyopharm Therapeutics For: Jan 02 | SEC filing · Form 8-K | +0.36% | +15.32% | |
| Form DEF 14A Karyopharm Therapeutics For: Jan 30 | SEC filing · Form DEF | +0.48% | +1.00% | |
| Form PRE 14A Karyopharm Therapeutics For: Dec 05 | SEC filing · Form PRE | +0.89% | -0.62% | |
| Form 8-K Karyopharm Therapeutics For: Dec 03 | SEC filing · Form 8-K | +1.12% | -1.22% | |
| Form 8-K Karyopharm Therapeutics For: Nov 20 | SEC filing · Form 8-K | +3.62% | +2.32% | |
| Form 8-K Karyopharm Therapeutics For: Nov 05 | SEC filing · Form 8-K | +0.58% | +5.35% | |
| Form 10-Q Karyopharm Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +2.45% | -7.08% | |
| Form 8-K Karyopharm Therapeutics For: Nov 05 | SEC filing · Form 8-K | +2.45% | -7.08% | |
| Form S-8 Karyopharm Therapeutics | SEC filing · Form S-8 | +2.45% | -7.08% | |
| Form 8-K Karyopharm Therapeutics For: Oct 31 | SEC filing · Form 8-K | -2.21% | +9.98% | |
| Form 8-K Karyopharm Therapeutics For: Sep 16 | SEC filing · Form 8-K | -3.82% | -5.58% | |
| Form 8-K Karyopharm Therapeutics For: Aug 26 | SEC filing · Form 8-K | +1.29% | -1.29% | |
| Form 10-Q Karyopharm Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +1.09% | -9.67% | |
| Form 8-K Karyopharm Therapeutics For: Aug 06 | SEC filing · Form 8-K | +1.09% | -9.67% | |
| Form EFFECT Karyopharm Therapeutics | SEC filing · Form EFFECT | +0.02% | +0.71% | |
| Form 8-K Karyopharm Therapeutics For: May 29 | SEC filing · Form 8-K | -0.52% | +0.95% | |
| Form S-3 Karyopharm Therapeutics | SEC filing · Form S-3 | -0.52% | +0.95% | |
| Form S-8 Karyopharm Therapeutics | SEC filing · Form S-8 | -0.52% | +0.95% | |
| Form 8-K Karyopharm Therapeutics For: May 13 | SEC filing · Form 8-K | +2.65% | +0.00% | |
| Form 10-Q Karyopharm Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -0.96% | +2.88% | |
| Form 8-K Karyopharm Therapeutics For: May 08 | SEC filing · Form 8-K | -0.85% | -9.73% | |
| Form ARS Karyopharm Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.87% | -7.14% | |
| Form DEF 14A Karyopharm Therapeutics For: May 29 | SEC filing · Form DEF | +0.87% | -7.14% | |
| Form DEFA14A Karyopharm Therapeutics | SEC filing · Form DEFA14A | +0.87% | -7.14% | |
| Form PRE 14A Karyopharm Therapeutics For: May 29 | SEC filing · Form PRE | +3.01% | +0.75% | |
| Form 10-K Karyopharm Therapeutics For: Dec 31 | SEC filing · Form 10-K | -4.17% | -12.78% | |
| Form 8-K Karyopharm Therapeutics For: Feb 29 | SEC filing · Form 8-K | -4.17% | -12.78% | |
| Form 8-K Karyopharm Therapeutics For: Feb 16 | SEC filing · Form 8-K | +2.80% | -0.82% | |
| Form 8-K Karyopharm Therapeutics For: Jan 08 | SEC filing · Form 8-K | +0.48% | +9.56% | |
| Form 8-K Karyopharm Therapeutics For: Dec 06 | SEC filing · Form 8-K | -2.42% | +4.89% | |
| Form 8-K Karyopharm Therapeutics For: Dec 05 | SEC filing · Form 8-K | -0.13% | +0.00% | |
| Form 10-Q Karyopharm Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +2.46% | -4.86% | |
| Form 8-K Karyopharm Therapeutics For: Nov 02 | SEC filing · Form 8-K | +2.46% | -4.86% |
Keep exploring
More KPTI: earnings → · analyst actions → · KPTI overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc. (ACAD) | 392 | -0.14% | 43% |
| BioXcel Therapeutics, Inc. (BTAI) | 392 | -0.75% | 41% |
| Rubius Therapeutics, Inc. (RUBY) | 392 | -0.32% | 45% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 391 | +0.13% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.